Antibody responses after intravaginal immunisation with trimeric HIV-1CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation
Open Access
- 25 December 2010
- Vol. 29 (7) , 1421-1430
- https://doi.org/10.1016/j.vaccine.2010.12.034
Abstract
No abstract availableKeywords
Funding Information
- Bill & Melinda Gates Foundation
- Wellcome Trust
- AIDS Vaccine Discovery/Comprehensive Antibody–Vaccine Immune Monitoring Consortium (38619)
This publication has 52 references indexed in Scilit:
- Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-LJournal of Virology, 2010
- Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected IndividualsPLOS ONE, 2010
- The use of immune complex vaccines to enhance antibody responses against neutralizing epitopes on HIV-1 envelope gp120Vaccine, 2009
- Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine TargetScience, 2009
- Vaginal delivery of the recombinant HIV-1 clade-C trimeric gp140 envelope protein CN54gp140 within novel rheologically structured vehicles elicits specific immune responsesVaccine, 2009
- Repeated vaginal administration of trimeric HIV-1 clade C gp140 induces serum and mucosal antibody responsesMucosal Immunology, 2009
- Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing TitersPLoS Pathogens, 2009
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialPublished by Elsevier ,2008
- A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120Virology, 2007
- HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sitesNature, 2002